Skip to main content
Top
Published in: International Cancer Conference Journal 2/2016

01-04-2016 | Case report

Spontaneously metachronous ruptures of adrenocortical carcinoma and its contralateral adrenal metastasis

Authors: Francesco A. Polistina, Angelo Farruggio, Pierpaola Gasparin, Sebastiano Pasquale, Mauro Frego

Published in: International Cancer Conference Journal | Issue 2/2016

Login to get access

Abstract

Adrenocortical carcinomas (ACCs) are rare neoplasms. In spite of its rarity, ACCs are the second most lethal endocrine cancer after anaplastic thyroid carcinomas. Currently, the only chance for a cure is an early diagnosis and a radical surgical resection. We present the case of a previously unreported bilateral adrenal hemorrhage occurring in a 59-year-old Caucasian male who was admitted to our surgical division with the diagnosis of a right retroperitoneal spontaneous hemorrhage. Imaging revealed a 10-cm ruptured right adrenal mass with no other abdominal lesions, endocrine screening results were normal, and a right adrenalectomy was performed. Pathology revealed a ruptured ACC. The postoperative period was uneventful and the patient was discharged. While recovering, 3 weeks after the operation, the patient showed the same symptoms on the contralateral side. Imaging once again revealed a retroperitoneal hemorrhage due to a 5-cm ruptured left adrenal mass. Endocrine screening showed a frank peripheral hypercortisolism and imaging showed a huge metastatic dissemination to the liver, lungs, and retroperitoneal space. An urgent left adrenalectomy was performed and pathology showed a metastatic ruptured ACC. The patient was placed in substitutive therapy but never recovered and died of penta lobar pneumonia on postoperative day 31. An extensive review of the current literature on the issue was performed. ACC is confirmed to be a lethal cancer. Rupture is the rarest clinical presentation and appears to be caused by the tumor’s growth rate more than the tumor dimensions itself. The use of endocrine screening on such hemodynamically unstable patients is questionable.
Literature
1.
go back to reference Hutter AM, Kayhoe DE (1966) Adrenal cortical carcinoma: clinical features in 138 patients. Am J Med 41:572CrossRefPubMed Hutter AM, Kayhoe DE (1966) Adrenal cortical carcinoma: clinical features in 138 patients. Am J Med 41:572CrossRefPubMed
3.
go back to reference Schteingart DE, Doherty GM, Gauger PG et al (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12(3):667–680CrossRefPubMed Schteingart DE, Doherty GM, Gauger PG et al (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12(3):667–680CrossRefPubMed
4.
go back to reference Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91(6):2027–2037CrossRefPubMed Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91(6):2027–2037CrossRefPubMed
5.
go back to reference Harrison LE, Gaudin PB, Brennan MF (1999) Pathologic features of prognostic significance for Adrenocortical carcinoma after curative resection. Arch Surg. 134:181–185CrossRefPubMed Harrison LE, Gaudin PB, Brennan MF (1999) Pathologic features of prognostic significance for Adrenocortical carcinoma after curative resection. Arch Surg. 134:181–185CrossRefPubMed
6.
go back to reference O’Kane HF, Duggan B, Lennon G et al (2002) Spontaneous rupture of adrenocortical carcinoma. J Urol 168(6):2530CrossRefPubMed O’Kane HF, Duggan B, Lennon G et al (2002) Spontaneous rupture of adrenocortical carcinoma. J Urol 168(6):2530CrossRefPubMed
7.
go back to reference Leung LY, Leung WY, Chan KF et al (2002) Ruptured adrenocortical carcinoma as a cause of paediatric acute abdomen. Pediatr Surg Int 18(8):730–732PubMed Leung LY, Leung WY, Chan KF et al (2002) Ruptured adrenocortical carcinoma as a cause of paediatric acute abdomen. Pediatr Surg Int 18(8):730–732PubMed
8.
go back to reference Liguori G, Trombetta C, Knez R et al (2003) Spontaneous rupture of adrenal carcinoma during the puerperal period. J Urol 170(5):1941CrossRefPubMed Liguori G, Trombetta C, Knez R et al (2003) Spontaneous rupture of adrenal carcinoma during the puerperal period. J Urol 170(5):1941CrossRefPubMed
9.
go back to reference Bussani R, Camilot D, Trombetta C et al (2003) Chance diagnosis of low stage non-metastasized adrenal cortical carcinoma in a young woman with retroperitoneal hemorrhage. Pathol Res Pract 199(11):761–763CrossRefPubMed Bussani R, Camilot D, Trombetta C et al (2003) Chance diagnosis of low stage non-metastasized adrenal cortical carcinoma in a young woman with retroperitoneal hemorrhage. Pathol Res Pract 199(11):761–763CrossRefPubMed
10.
go back to reference Stamoulis JS, Antonopoulou Z, Safioleas M (2004) Haemorrhagic shock from the spontaneous rupture of an adrenal cortical carcinoma. A case report. Acta Chir Belg. 104(2):226–228PubMed Stamoulis JS, Antonopoulou Z, Safioleas M (2004) Haemorrhagic shock from the spontaneous rupture of an adrenal cortical carcinoma. A case report. Acta Chir Belg. 104(2):226–228PubMed
11.
go back to reference Suyama K, Beppu T, Isiko T et al (2007) Spontaneous rupture of adrenocortical carcinoma. Am J Surg. 194(1):77–78CrossRefPubMed Suyama K, Beppu T, Isiko T et al (2007) Spontaneous rupture of adrenocortical carcinoma. Am J Surg. 194(1):77–78CrossRefPubMed
12.
go back to reference Kasperlik-Zaluska AA, Zgliczynski W, Slapa RZ et al (2008) Retroperitoneal hemorrhage from adrenocortical carcinoma as a poor prognostic factor. Int J Biomed Sci. 4(1):78–81PubMedPubMedCentral Kasperlik-Zaluska AA, Zgliczynski W, Slapa RZ et al (2008) Retroperitoneal hemorrhage from adrenocortical carcinoma as a poor prognostic factor. Int J Biomed Sci. 4(1):78–81PubMedPubMedCentral
13.
go back to reference Lu CY, Yen TH, Hsieh ML et al (2009) Spontaneous rupture of adrenocortical carcinoma: a coincidence or a tendency? Clin Nephrol 72(2):147–150CrossRefPubMed Lu CY, Yen TH, Hsieh ML et al (2009) Spontaneous rupture of adrenocortical carcinoma: a coincidence or a tendency? Clin Nephrol 72(2):147–150CrossRefPubMed
15.
go back to reference Sakata R, Tsuchiya F, Osaka K et al (2012) Adrenocortical carcinoma detected by retroperitoneal hemorrhage: a case report. Hinyokika Kiyo. 58(3):149–153PubMed Sakata R, Tsuchiya F, Osaka K et al (2012) Adrenocortical carcinoma detected by retroperitoneal hemorrhage: a case report. Hinyokika Kiyo. 58(3):149–153PubMed
18.
go back to reference Birsen O, Akyuz M, Dural C et al (2014) A new risk stratification algorithm for the management of patients with adrenal incidentalomas. Surgery 156(4):959–965CrossRefPubMed Birsen O, Akyuz M, Dural C et al (2014) A new risk stratification algorithm for the management of patients with adrenal incidentalomas. Surgery 156(4):959–965CrossRefPubMed
19.
go back to reference Kouyama R, Hiraishi K, Sugiyama T et al (2011) Clinicopathological features, biochemical and molecular markers in 5 patients with adrenocortical carcinoma. Endocr J 58(7):527–534CrossRefPubMed Kouyama R, Hiraishi K, Sugiyama T et al (2011) Clinicopathological features, biochemical and molecular markers in 5 patients with adrenocortical carcinoma. Endocr J 58(7):527–534CrossRefPubMed
20.
go back to reference Pua U, Wong DE (2008) Transarterial embolisation of spontaneous adrenal pheochromocytoma rupture using polyvinyl alcohol particles. Singapore Med J 49(5):e126–e130PubMed Pua U, Wong DE (2008) Transarterial embolisation of spontaneous adrenal pheochromocytoma rupture using polyvinyl alcohol particles. Singapore Med J 49(5):e126–e130PubMed
21.
go back to reference Hendrickson RJ, Katzman PJ, Queiroz R et al (2001) Management of massive retroperitoneal hemorrhage from an adrenal tumor. Endocr J 48(6):691–696CrossRefPubMed Hendrickson RJ, Katzman PJ, Queiroz R et al (2001) Management of massive retroperitoneal hemorrhage from an adrenal tumor. Endocr J 48(6):691–696CrossRefPubMed
22.
go back to reference Ronchi CL, Kroiss M, Sbiera S et al (2014) EJE prize 2014: current and evolving treatment options in adrenocortical carcinoma: where do we stand and where do we want to go? Eur J Endocrinol 171(1):R1–R11. doi:10.1530/EJE-14-0273 CrossRefPubMed Ronchi CL, Kroiss M, Sbiera S et al (2014) EJE prize 2014: current and evolving treatment options in adrenocortical carcinoma: where do we stand and where do we want to go? Eur J Endocrinol 171(1):R1–R11. doi:10.​1530/​EJE-14-0273 CrossRefPubMed
25.
go back to reference Sasano H, Suzuki T, Moriya T (2006) Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol Winter 17(4):345–354CrossRef Sasano H, Suzuki T, Moriya T (2006) Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma. Endocr Pathol Winter 17(4):345–354CrossRef
Metadata
Title
Spontaneously metachronous ruptures of adrenocortical carcinoma and its contralateral adrenal metastasis
Authors
Francesco A. Polistina
Angelo Farruggio
Pierpaola Gasparin
Sebastiano Pasquale
Mauro Frego
Publication date
01-04-2016
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 2/2016
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-015-0235-5

Other articles of this Issue 2/2016

International Cancer Conference Journal 2/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine